ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

RQ Biotechnology Limited

RQ Biotechnology Limited is an active company incorporated on 26 March 2021 with the registered office located in London, Greater London. RQ Biotechnology Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13293828
Private limited company
Age
4 years
Incorporated 26 March 2021
Size
Unreported
Confirmation
Submitted
Dated 25 March 2025 (7 months ago)
Next confirmation dated 25 March 2026
Due by 8 April 2026 (5 months remaining)
Last change occurred 7 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2025 (12 months)
Accounts type is Full
Next accounts for period 31 March 2026
Due by 31 December 2026 (1 year 2 months remaining)
Address
Scale Space
58 Wood Lane
London
W12 7RZ
United Kingdom
Address changed on 29 Jun 2023 (2 years 4 months ago)
Previous address was 7th Floor Lynton House 7-12 Tavistock Square London WC1H 9LT United Kingdom
Telephone
Unreported
Email
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in England • Born in Jun 1966
Director • British,canadian • Lives in England • Born in Dec 1973
RQ Biotechnology Holdings Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
RQ Biotechnology Holdings Limited
Clare Elizabeth Terlouw and Dr Michael Westby are mutual people.
Active
Bioindustry Association
Clare Elizabeth Terlouw is a mutual person.
Active
Closed Loop Medicine Ltd
Clare Elizabeth Terlouw is a mutual person.
Active
Imophoron Limited
Dr Michael Westby is a mutual person.
Active
Ensocell Ltd
Clare Elizabeth Terlouw is a mutual person.
Active
Rqbio Covid Limited
Clare Elizabeth Terlouw is a mutual person.
Active
Erpin Bio Limited
Clare Elizabeth Terlouw is a mutual person.
Active
Cumulus Neuroscience Limited
Clare Elizabeth Terlouw is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2022–2025)
Period Ended
31 Mar 2025
For period 31 Mar31 Mar 2025
Traded for 12 months
Cash in Bank
£10.89M
Decreased by £4.93M (-31%)
Turnover
Unreported
Decreased by £12.06M (-100%)
Employees
12
Increased by 1 (+9%)
Total Assets
£13.01M
Decreased by £3.55M (-21%)
Total Liabilities
-£914K
Decreased by £203K (-18%)
Net Assets
£12.09M
Decreased by £3.35M (-22%)
Debt Ratio (%)
7%
Increased by 0.28% (+4%)
Latest Activity
Full Accounts Submitted
3 Months Ago on 28 Jul 2025
Confirmation Submitted
7 Months Ago on 31 Mar 2025
Full Accounts Submitted
1 Year 3 Months Ago on 25 Jul 2024
William Ripley Ballou Resigned
1 Year 6 Months Ago on 9 Apr 2024
Jacques Cholat Resigned
1 Year 6 Months Ago on 9 Apr 2024
Rq Biotechnology Holdings Limited (PSC) Appointed
1 Year 6 Months Ago on 8 Apr 2024
Lifearc (PSC) Resigned
1 Year 6 Months Ago on 8 Apr 2024
Confirmation Submitted
1 Year 7 Months Ago on 27 Mar 2024
Own Shares Purchased
1 Year 12 Months Ago on 6 Nov 2023
Full Accounts Submitted
2 Years Ago on 25 Oct 2023
Get Credit Report
Discover RQ Biotechnology Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Full accounts made up to 31 March 2025
Submitted on 28 Jul 2025
Confirmation statement made on 25 March 2025 with updates
Submitted on 31 Mar 2025
Memorandum and Articles of Association
Submitted on 6 Sep 2024
Full accounts made up to 31 March 2024
Submitted on 25 Jul 2024
Cessation of Lifearc as a person with significant control on 8 April 2024
Submitted on 5 Jun 2024
Notification of Rq Biotechnology Holdings Limited as a person with significant control on 8 April 2024
Submitted on 5 Jun 2024
Termination of appointment of Jacques Cholat as a director on 9 April 2024
Submitted on 9 Apr 2024
Termination of appointment of William Ripley Ballou as a director on 9 April 2024
Submitted on 9 Apr 2024
Confirmation statement made on 25 March 2024 with updates
Submitted on 27 Mar 2024
Purchase of own shares.
Submitted on 6 Nov 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year